Title : Ibrutinib (PCI-32765), the first BTK (Bruton's tyrosine kinase) inhibitor in clinical trials.

Pub. Date : 2013 Mar

PMID : 23296407






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ibrutinib (PCI-32765), the first BTK (Bruton"s tyrosine kinase) inhibitor in clinical trials. ibrutinib Bruton tyrosine kinase Homo sapiens
2 Ibrutinib (PCI-32765), the first BTK (Bruton"s tyrosine kinase) inhibitor in clinical trials. ibrutinib Bruton tyrosine kinase Homo sapiens
3 Ibrutinib is a potent covalent kinase inhibitor that targets BTK. ibrutinib Bruton tyrosine kinase Homo sapiens